Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Future therapies for food allergy.
Anna Nowak-Wegrzyn
Icahn School of Medicine at Mount Sinai
Research output
:
Contribution to journal
›
Review article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Future therapies for food allergy.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Practice
100%
Food Allergy
100%
Milk
100%
Future Therapies
100%
Dietary Avoidance
100%
Public Health Risk
50%
Clinical Trials
50%
Allergic Diseases
50%
Allergic children
50%
Baked Egg
50%
Baked Milk
50%
Safer Alternatives
50%
Patient-specific Therapy
50%
Food Allergy Prevention
50%
Current Management
50%
Allergen-specific
50%
Oral Immunotherapy
50%
Oral Tolerance
50%
Anti-IgE Antibody
50%
IgE-mediated Allergy
50%
Immediate Future
50%
Food Oral Immunotherapy
50%
Extensively Heated
50%
Medicine and Dentistry
Food Allergy
100%
Oral Immunotherapy
50%
Public Health
25%
Clinical Trial
25%
Immunoglobulin E
25%
Immunoglobulin E Antibody
25%
Oral Tolerance
25%
Allergen
25%
Lifestyle
25%
Immunology and Microbiology
Food Allergy
100%
Immunotherapy
50%
Immunoglobulin E
25%
Allergen
25%
Immunoglobulin E Antibody
25%